KORU Medical Systems, Inc. financial data

Symbol
KRMD on Nasdaq
Location
100 Corporate Drive, Mahwah, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 273 % -37%
Quick Ratio 51 % -31.5%
Debt-to-equity 59.2 % +53.5%
Return On Equity -26.8 % +51.3%
Return On Assets -16.8 % +57.6%
Operating Margin -13.2 % +43.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.2M shares +0.83%
Common Stock, Shares, Outstanding 46.2M shares +0.91%
Entity Public Float 83.5M USD -24.9%
Common Stock, Value, Issued 497K USD +0.84%
Weighted Average Number of Shares Outstanding, Basic 46M shares +0.59%
Weighted Average Number of Shares Outstanding, Diluted 46.2M shares +0.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 36.8M USD +19.6%
Research and Development Expense 4.96M USD -4.49%
Operating Income (Loss) -4.85M USD +32.1%
Nonoperating Income (Expense) 356K USD -32.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -190K USD +80.8%
Income Tax Expense (Benefit) 17.4K USD
Net Income (Loss) Attributable to Parent -4.52M USD +61.6%
Earnings Per Share, Basic 0 USD/shares +33.3%
Earnings Per Share, Diluted 0 USD/shares -14.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.05M USD -23%
Accounts Receivable, after Allowance for Credit Loss, Current 4.93M USD -15.7%
Inventory, Net 3.95M USD +52.5%
Assets, Current 17.6M USD -9.22%
Deferred Income Tax Assets, Net 5.45M USD +54.7%
Property, Plant and Equipment, Net 4.37M USD +18.8%
Operating Lease, Right-of-Use Asset 2.77M USD -18.9%
Other Assets, Noncurrent 99K USD 0%
Assets 25.5M USD -6.55%
Accounts Payable, Current 1.09M USD -31.4%
Employee-related Liabilities, Current 689K USD +55.1%
Accrued Liabilities, Current 3.64M USD +69.5%
Liabilities, Current 6.05M USD +17.8%
Operating Lease, Liability, Noncurrent 2.79M USD -12.8%
Liabilities 8.99M USD +4.55%
Retained Earnings (Accumulated Deficit) -30.8M USD -17.2%
Stockholders' Equity Attributable to Parent 16.5M USD -11.6%
Liabilities and Equity 25.5M USD -6.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -237K USD +31.5%
Net Cash Provided by (Used in) Financing Activities -161K USD +11.7%
Net Cash Provided by (Used in) Investing Activities -447K USD -236%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 49.7M shares +0.81%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -845K USD -27.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.39K USD -56.2%
Deferred Tax Assets, Valuation Allowance 7.08M USD +18%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 8.32M USD +20%
Operating Lease, Liability 3.4M USD -8.21%
Depreciation 228K USD +14%
Property, Plant and Equipment, Gross 8.23M USD +20.8%
Operating Lease, Liability, Current 409K USD +4.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 534K USD +4.28%
Lessee, Operating Lease, Liability, to be Paid, Year One 534K USD +4.28%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 534K USD +4.28%
Lessee, Operating Lease, Liability, to be Paid, Year Four 521K USD +1.74%
Operating Lease, Payments 129K USD +7.48%
Depreciation, Depletion and Amortization 866K USD -3.08%
Deferred Tax Assets, Net of Valuation Allowance 1.24M USD +33.1%